Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice (Q40762438)

23 September 2017

title

Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice (English)

1 reference

23 September 2017

0 references

1 reference

Brodie SG

1

1 reference

23 September 2017

Xu X

2

1 reference

23 September 2017

Qiao W

3

1 reference

23 September 2017

Li WM

4

1 reference

23 September 2017

Cao L

5

1 reference

23 September 2017

Deng CX

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

20

1 reference

23 September 2017

issue

51

1 reference

23 September 2017

page(s)

7514-7523

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204929

23 September 2017

exact match

0 references

cites work

BRCA1-associated growth arrest is RB-dependent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Cyclin D1 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Genetic alterations in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Breast cancer susceptibility genes. BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Apoptosis in antitumor strategies: modulation of cell cycle or differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Apoptosis in cancer therapy: crossing the threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

BRCA1 mutations in primary breast and ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

BRCA1 required for transcription-coupled repair of oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Transgenic mouse models of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Cancer-susceptibility genes. Gatekeepers and caretakers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Role of HER2 gene overexpression in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Brca1 controls homology-directed DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Casein kinase 2 binds to and phosphorylates BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

BRCA1: a review of structure and putative functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Association of BRCA1 with Rad51 in mitotic and meiotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

21 January 2018

BRCA1 and cell signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Identification of a RING protein that can interact in vivo with the BRCA1 gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Mutations of the BRCA1 gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

Epidemiology, prevention, and early detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

p27kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Deletion mapping of chromosomal region 1p32-pter in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Gene amplification and tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Breast cancer genes--what are the real risks?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Genetic background alters the spectrum of tumors that develop in p53-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Tumour biological features of BRCA1-induced breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Expression of cell cycle-regulatory proteins rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

At least five regions of imbalance on 6q in breast tumors, combining losses and gains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Multiple copies of mutantBRCA1 andBRCA2 alleles in breast tumors from germ-line mutation carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Oestrogen receptor and its potential role in breast cancer development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204929

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204929

1 reference

Dimensions Publication ID

23 September 2017

1023709287

0 references

1 reference